
Learn the Targeted muscle re-innervation for superficial radial neuroma surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Targeted muscle re-innervation for superficial radial neuroma surgical procedure.
Targeted muscle reinnervation (TMR) is a technique developed for the management of symptomatic neuromas. The ideal method of management for a neuroma is not clear. Different techniques may be required for different nerves in different locations. As a general rule though, reconstruction of the nerve gap created after resection of a neuroma is the optimum method of restoring some afferent signalling to the sensory cortex of the brain. Reconstructive procedures like this depend on the tissue bed, the quality of the distal nerve stump and the nerve gap.
Bridging a gap requires nerve graft and for some patients, the thought of creating a second nerve injury site for autologous nerve graft harvest, with the attendant risks of neuroma, sensory loss and neuropathic pain, is an unacceptable solution. TMR has demonstrated excellent results in the prevention of phantom pain, in the management of limb pain following amputation and in treating both mixed nerves and pure sensory nerves. The technique is “active” or reconstructive, directing regenerating axons into a distal motor branch of a nerve in the vicinity.
The superficial radial nerve is challenging to treat when sensitised, due to the prominent location and tendency fro irritation by contact from clothing. There is no wholly reliable method for management of the SRN. Applying the technique of TMR to the SRN is starting to demonstrate promise.
This technique demonstrates the use of TMR to treat a SRN proximal stump to the distal anterior interosseous nerve (AIN) to pronator quadratus (PQ) for the management of neuroma pain that followed injury to the SRN during injection to the thumb CMCJ. The initial attempts at neuroma management included in situ capping and relief was temporary, again becoming problematic at 2 years and being accompanied by CMCJ deterioration, in this case with pre-existing arthritis. Definitive treatment of the CMCJ arthritis with excision arthroplasty was planned and a decision to undertake TMR of the SRN at the same time was based on an attempt to find a more permanent resolution of the neuropathic pain.

Indications:
The prime indication for this procedure is persistent neuropathic pain from a neuroma of the SRN where there is a contra-indication to reconstruction to the distal nerve stump. The technique is currently considered a salvage option due to the large area of skin denervation necessary from resection of the whole of the SRN trunk, even when the symptomatic neuroma may be on one of the main branches.
Symptoms and examination:
Symptomatic neuromas are associated with both contact “evoked” pain and “spontaneous” pain. The pain is characteristically neuropathic with sensations of tingling, burning or shooting often described by patients. There is usually extreme sensitivity to light touch with the hallmarks of dysaesthesia, allodynia and hyperalgesia. There is often avoidance behaviour. Patients will often have tried a number of different analgesic and neuromodulator medications to control their symptoms without long term benefit. There is usually notable apprehension when attempting to examine a patient with a cutaneous neuroma and they may flinch in anticipation of contact or draw their limb away. The examiner must be sensitive to the patient’s concerns and build up a rapport. Gently tapping from distal in a proximal direction along the course of the nerve under test may elicit a Tinel’s sign at the point of nerve irritation or neuroma. The Tinel’s sign, is positive when tingling or pins and needles is reported by the patient in the cutaneous territory of the nerve under test. The tingling sensations can be profound and prolonged and so to accurately determine the neuroma site, the examiner should avoid the main nerve trunk by commencing the examination distal to the neuroma and moving towards the neuroma and the nerve trunk.
Investigations:
A diagnostic peripheral nerve block under ultrasound guidance is recommended to determine that the symptomatic neuroma arises from the SRN. There is considerable overlap between the cutaneous territories of the SRN and the lateral cutaneous nerve of the forearm (LCNF) and often there are interconnecting branches in the periphery. The site of nerve block is therefore cricital. Blocking in the proximal forearm risks overspill of local anaesthetic to the adjacent nerve. The SRN lies here deep to the brachioradialis muscle and the LCNF lies in the superficial fat adjacent to the cephalic vein. A better site for blockade of the radial nerve is in the upper arm as it emerges from the spiral groove at the lateral 1/3 of the humerus. A small volume of local anaesthetic is required because more then 5 mls may spread distally to the interval between the biceps and the brachialis and affect a block of the LCNF as it emerges lateral to the biceps tendon.
An ultrasound of the site of suspected neuroma may be performed. In some patients the area is so sensitive that US must be reserved from after the nerve block. In other cases, MRI may be preferable to avoid the contact irritation of the neuroma.
Conservative management:
Sensitive neuromas may be initially managed with desensitisation and neuromodulation physical therapy and oral neuromodulator medications. Central sensitisation pain may be optimised through mirror feedback therapy. Non-surgical methods of management may also include radiofrequency blockade and cryotherapy. Persistent neuropathic pain may require surgical management of the neuroma.
Alternative operative management:
There are numerous surgical procedures that have been described for the management of painful cutaneous neuromas. Resection and in-situ capping prevents adherence of any recurrent neuroma to the environment. Burying to bone or muscle are commonplace, although the evidence to support these techniques is poor. Loop co-aptation to a second nerve when there is another neuroma may provide a conduit for regeneration. Using processed nerve allograft to create a “graft to nowhere” is another option. For neuromas in continuity, neurolysis and wrapping with veins and collagen sheets may help pain. Resurfacing can be used when the soft tissues are of poor quality. When there is a poor distal function our no distal function, a neuroma in continuity may be resected and reconstructed with processed nerve allograft, without the risks associated with autologous nerve graft harvest from another site. In severe recalcitrant cases of neuropathic pain in damaged nerves, peripheral nerve implantable stimulators may be used to block the
Contraindication:
Surgery is not recommended when there is no defined neuroma site, there is no good response to the diagnostic nerve block, there is poor soft tissue at the site of the planned surgery, when there is active infection, in cases where the patient does not comprehend the problem or is non-compliant with the management plan.

The patient should have their pain medically optimised and neuromodulator medications are invaluable.
The surgery requires a basic hand tray with West and Travers self-retaining retractors. A lead hand helps with limb positioning. Surgical silicone elastic loops are useful for tagging, retracting and handling the nerves to avoid trauma.
Micro-instrumentation, an operating microscope, background material and microsurgical sutures are required for the co-aptation which can be supported by Tisseel fibrin glue.
A nerve catheter may be placed proximal to the neuroma resection site on the affected nerve to help with peri-operative pain management.
The patient can have either a general anaesthetic with a regional block addition, or regional anaesthesia in isolation.
An arm tourniquet and wool padding should be applied to the upper arm.

The WHO signet is completed.
The limb is dressed and placed in a volar slab of Plaster of Paris to provide some post-operative splinting and to prevent excessive motion of the wrist. In this case there was a concomitant trapezium excision and reconstruction.
Typically a cast for TMR in the upper limb is used until first dressing change at 7-10 days post-operatively. The splint doe not need to continue beyond this point as there is no tension in the nerve co-aptation due to the donor distal and recipient proximal arrangement of the neurorraphy which renders is tension free.
The limb should be monitored after tourniquet release to ensure that there is no bleeding, digital perfusion is normal and the dressings are not too constricting.
The operation note and discharge summary are completed.
Take home analgesic medications are prescribed.
A review in the clinic is planned for 7-10 days post-operatively when the dressings will be removed, the wound assessed and early mobilisation can be commenced.
I recommend that is the patient is already on neuromodular medications, then these should be continued in the per-operative period for 6-12 weeks before graduated reduction.
Cognitive therapies, neurorehabilitation strategies and mirror therapy can be commenced when the wound is left open.
Topical management of the wound with massage and emollient massage reduced sensitisation, encourages engagement, reduced avoidance and can speed up the process of scar maturation.
The expectation os that the neuropathic pain will reduce in the 6-12 weeks following the surgery. The improvement may be monitored using pain scores, neuroma scores and an analgesia diary.

TMR is a relatively new application of nerve transfer surgery aimed at reducing neuropathic pain from neuromas and the phantom limb pain experiences following amputation. The evidence in lower limb amputation as an intervention for neuroma and as prophylaxis during the index amputation period is good. Well constructed randomised controlled trials have been completed to support the emerging evidence base. The role of TMR is sensory nerve neuroma management is less well defined. The introduction of the technique to the “toolbox” for neuroma reconstruction is based on the variable results of the existing techniques. Simple neuroma resection, capping, burying to muscle or bone or “allografts to nowhere” are all described and have their proponents, however in a case with a distal nerve stump an active (reconstructive) technique is to be recommended, restoring the afferent pathway. When there is no distal nerve stump available for a graft, typically passive (ablative) procedures are performed, although using an active technique (graft to nowhere or TMR) provide an interval with reduced evoked pain and allow central down regulation of the pain pathways.
References:
Arnold DMJ, Wilkens SC, Coert JH, Chen NC, Ducic I, Eberlin KR. Diagnostic Criteria for Symptomatic Neuroma. Ann Plast Surg. 2019 Apr;82(4):420-427.
doi: 10.1097/SAP.0000000000001796. Erratum in: Ann Plast Surg. 2019 Jul;83(1):120. PubMed PMID: 30855369
This paper describes the diagnostic criteria for defining a neuroma. In a case with a history consistent with a nerve injury, poor recovery, a positive Tinel’s sign and good pain response to a local anaesthetic block, then a neuroma may be diagnoses. The neuroma may be confirmed with US or MRI imaging.
Eberlin KR, Ducic I. Surgical Algorithm for Neuroma Management: A Changing Treatment Paradigm. Plast Reconstr Surg Glob Open. 2018 Oct 16;6(10):e1952.
doi: 10.1097/GOX.0000000000001952. eCollection 2018 Oct. PubMed PMID: 30534497; PubMed Central PMCID: PMC6250458
This paper reports the different methods for surgical management of neuromas and classifies procedures as ablative / passive or reconstructive / active.The techniques of TMR and RPNI are discussed in the active category alongside grafts to nowehere, graft to distal stump and loop Centro-central anastomosis.
Salminger S, Sturma A, Roche AD, Mayer JA, Gstoettner C, Aszmann OC. Outcomes, Challenges, and Pitfalls after Targeted Muscle Reinnervation in High-Level Amputees: Is It Worth the Effort? Plast Reconstr Surg. 2019 Dec;144(6):1037e-1043e.
doi: 10.1097/PRS.0000000000006277. PubMed PMID: 31764652
30 patients with upper limb amputation were treated, 19 for improved prosthetic control and 11 for neuroma pain management over a 5 year period. All achieved a myoelectric signal and in the 10 at final follow up analysis there was improved function. There were cases of abandonment of prosthetics after otherwise successful surgery and the conclusion was that there would need to be improvements in the biotechnological interface to improve adoption and long term use of advanced prosthetics in the future.
Chappell AG, Jordan SW, Dumanian GA. Targeted Muscle Reinnervation for Treatment of Neuropathic Pain. Clin Plast Surg. 2020 Apr;47(2):285-293. doi: 10.1016/j.cps.2020.01.002. Epub 2020 Feb 5. Review.
PubMed PMID: 32115054
This review reports that the development of an active regeneration through TMR is superior to direct muscle implantation in the management of nerve pain.
Fracol ME, Dumanian GA, Janes LE, Bai J, Ko JH. Management of Sural Nerve Neuromas with Targeted Muscle Reinnervation. Plast Reconstr Surg Glob Open. 2020 Jan 17;8(1):e2545.
doi: 10.1097/GOX.0000000000002545. eCollection 2020 Jan. PubMed PMID: 32095388; PubMed Central PMCID: PMC7015593
This paper explores the concept of sensory only TMR for the prevention or management of neuroma pain. The technique ds=escribes direct transfer of the rural nerve proximal stump to the lateral gastrocnemius branch to direct the regenerating sensory axons to deeper tissues, away from the skin.
Janes LE, Fracol ME, Ko JH, Dumanian GA. Management of Unreconstructable Saphenous Nerve Injury with Targeted Muscle Reinnervation. Plast Reconstr Surg Glob Open. 2020 Jan 17;8(1):e2383.
doi: 10.1097/GOX.0000000000002383. eCollection 2020 Jan. PubMed PMID: 32095383; PubMed Central PMCID: PMC7015600
This clinical series of 18 cases reports saphenous branch transfer to adjacent motor branches. Two patients had recurrent pain, 6 were lost to follow-up and 10 noted pain resolution after the TMR.
Alexander JH, Jordan SW, West JM, Compston A, Fugitt J, Bowen JB, Dumanian GA, Pollock R, Mayerson JL, Scharschmidt TJ, Valerio IL. Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol. J Surg Oncol. 2019 Sep;120(3):348-358. doi: 10.1002/jso.25586. Epub 2019 Jun 13. PubMed PMID: 31197851
This is a cohort study of 31 patients having primary TMR at the time of oncologic amputations. The authors report fewer neuromas and less neuroma pain intensity than in a cross-section sample of oncological amputees treated elsewhere.
Valerio IL, Dumanian GA, Jordan SW, Mioton LM, Bowen JB, West JM, Porter K, Ko JH, Souza JM, Potter BK. Preemptive Treatment of Phantom and Residual Limb Pain with Targeted Muscle Reinnervation at the Time of Major Limb Amputation. J Am Coll Surg. 2019 Mar;228(3):217-226. doi: 10.1016/j.jamcollsurg.2018.12.015. Epub 2019 Jan 8. PubMed PMID: 30634038
This is a multi-institutional cohort study of 51 patients undergoing TMR at the time of major limb amputation compared to 438 major limb amputees. A number of measures were performed including a PROMIS score and a numerical rating scale. The interventional cohort experiences less phantom limb pain and less residual limb pain. The authors recommend TMR at the time of amputation to reduce limb pain and phantom pain.
Dumanian GA, Potter BK, Mioton LM, Ko JH, Cheesborough JE, Souza JM, Ertl WJ, Tintle SM, Nanos GP, Valerio IL, Kuiken TA, Apkarian AV, Porter K, Jordan SW. Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial. Ann Surg. 2019 Aug;270(2):238-246. doi: 10.1097/SLA.0000000000003088. PubMed PMID: 30371518
This is an RCT and 28 patients with limb pain after amputation were randomised to either standard care or TMR. There were 3 cross-over patients to the TMR arm. The authors recommend TMR for the management of residual limb pain.
Bowen JB, Ruter D, Wee C, West J, Valerio IL. Targeted Muscle Reinnervation Technique in Below-Knee Amputation. Plast Reconstr Surg. 2019 Jan;143(1):309-312. doi: 10.1097/PRS.0000000000005133. PubMed PMID: 30589808
This study reports on the use of TMR in the management of below knee amputation patients and notes that untreated there is a rate of 25% residual limb pain. All patients report phantom pain at 1 month, however by 3 months, all patients had phantom limb pain resolution. The patients were followed to one year and the paper supports extending the use of TMR to the below knee amputation patient.
Arnold DMJ, Wilkens SC, Coert JH, Chen NC, Ducic I, Eberlin KR. Diagnostic Criteria for Symptomatic Neuroma. Ann Plast Surg. 2019 Apr;82(4):420-427. doi: 10.1097/SAP.0000000000001796. Erratum in: Ann Plast Surg. 2019 Jul;83(1):120. PubMed PMID: 30855369
This paper describes the diagnostic criteria for defining a neuroma. In a case with a history consistent with a nerve injury, poor recovery, a positive Tinel’s sign and good pain response to a local anaesthetic block, then a neuroma may be diagnoses. The neuroma may be confirmed with US or MRI imaging.
Eberlin KR, Ducic I. Surgical Algorithm for Neuroma Management: A Changing Treatment Paradigm. Plast Reconstr Surg Glob Open. 2018 Oct 16;6(10):e1952. doi: 10.1097/GOX.0000000000001952. eCollection 2018 Oct. PubMed PMID: 30534497; PubMed Central PMCID: PMC6250458
This paper reports the different methods for surgical management of neuromas and classifies procedures as ablative / passive or reconstructive / active.The techniques of TMR and RPNI are discussed in the active category alongside grafts to nowehere, graft to distal stump and loop Centro-central anastomosis.
Salminger S, Sturma A, Roche AD, Mayer JA, Gstoettner C, Aszmann OC. Outcomes, Challenges, and Pitfalls after Targeted Muscle Reinnervation in High-Level Amputees: Is It Worth the Effort? Plast Reconstr Surg. 2019 Dec;144(6):1037e-1043e. doi: 10.1097/PRS.0000000000006277. PubMed PMID: 31764652
30 patients with upper limb amputation were treated, 19 for improved prosthetic control and 11 for neuroma pain management over a 5 year period. All achieved a myoelectric signal and in the 10 at final follow up analysis there was improved function. There were cases of abandonment of prosthetics after otherwise successful surgery and the conclusion was that there would need to be improvements in the biotechnological interface to improve adoption and long term use of advanced prosthetics in the future.
Chappell AG, Jordan SW, Dumanian GA. Targeted Muscle Reinnervation for Treatment of Neuropathic Pain. Clin Plast Surg. 2020 Apr;47(2):285-293. doi: 10.1016/j.cps.2020.01.002. Epub 2020 Feb 5. Review. PubMed PMID: 32115054
This review reports that the development of an active regeneration through TMR is superior to direct muscle implantation in the management of nerve pain.
Fracol ME, Dumanian GA, Janes LE, Bai J, Ko JH. Management of Sural Nerve Neuromas with Targeted Muscle Reinnervation. Plast Reconstr Surg Glob Open. 2020 Jan 17;8(1):e2545. doi: 10.1097/GOX.0000000000002545. eCollection 2020 Jan. PubMed PMID: 32095388; PubMed Central PMCID: PMC7015593
This paper explores the concept of sensory only TMR for the prevention or management of neuroma pain. The technique ds=escribes direct transfer of the rural nerve proximal stump to the lateral gastrocnemius branch to direct the regenerating sensory axons to deeper tissues, away from the skin.
Janes LE, Fracol ME, Ko JH, Dumanian GA. Management of Unreconstructable Saphenous Nerve Injury with Targeted Muscle Reinnervation. Plast Reconstr Surg Glob Open. 2020 Jan 17;8(1):e2383. doi: 10.1097/GOX.0000000000002383. eCollection 2020 Jan. PubMed PMID: 32095383; PubMed Central PMCID: PMC7015600
This clinical series of 18 cases reports saphenous branch transfer to adjacent motor branches. Two patients had recurrent pain, 6 were lost to follow-up and 10 noted pain resolution after the TMR.
Alexander JH, Jordan SW, West JM, Compston A, Fugitt J, Bowen JB, Dumanian GA, Pollock R, Mayerson JL, Scharschmidt TJ, Valerio IL. Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol. J Surg Oncol. 2019 Sep;120(3):348-358. doi: 10.1002/jso.25586. Epub 2019 Jun 13. PubMed PMID: 31197851
This is a cohort study of 31 patients having primary TMR at the time of oncologic amputations. The authors report fewer neuromas and less neuroma pain intensity than in a cross-section sample of oncological amputees treated elsewhere.
Valerio IL, Dumanian GA, Jordan SW, Mioton LM, Bowen JB, West JM, Porter K, Ko JH, Souza JM, Potter BK. Preemptive Treatment of Phantom and Residual Limb Pain with Targeted Muscle Reinnervation at the Time of Major Limb Amputation. J Am Coll Surg. 2019 Mar;228(3):217-226. doi: 10.1016/j.jamcollsurg.2018.12.015. Epub 2019 Jan 8. PubMed PMID: 30634038
This is a multi-institutional cohort study of 51 patients undergoing TMR at the time of major limb amputation compared to 438 major limb amputees. A number of measures were performed including a PROMIS score and a numerical rating scale. The interventional cohort experiences less phantom limb pain and less residual limb pain. The authors recommend TMR at the time of amputation to reduce limb pain and phantom pain.
Dumanian GA, Potter BK, Mioton LM, Ko JH, Cheesborough JE, Souza JM, Ertl WJ, Tintle SM, Nanos GP, Valerio IL, Kuiken TA, Apkarian AV, Porter K, Jordan SW. Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial. Ann Surg. 2019 Aug;270(2):238-246. doi: 10.1097/SLA.0000000000003088. PubMed PMID: 30371518
This is an RCT and 28 patients with limb pain after amputation were randomised to either standard care or TMR. There were 3 cross-over patients to the TMR arm. The authors recommend TMR for the management of residual limb pain.
Bowen JB, Ruter D, Wee C, West J, Valerio IL. Targeted Muscle Reinnervation Technique in Below-Knee Amputation. Plast Reconstr Surg. 2019 Jan;143(1):309-312. doi: 10.1097/PRS.0000000000005133. PubMed PMID: 30589808
This study reports on the use of TMR in the management of below knee amputation patients and notes that untreated there is a rate of 25% residual limb pain. All patients report phantom pain at 1 month, however by 3 months, all patients had phantom limb pain resolution. The patients were followed to one year and the paper supports extending the use of TMR to the below knee amputation patient.
Reference
- orthoracle.com

























































